Profitability
by Company within Major Pharmaceutical Preparations Industry
|
| Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
| Abeona Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| Abbott Laboratories |
1 Q |
57.91 % |
17.15 % |
11.63 % |
17.72 % |
| Arbutus Biopharma Corp |
1 Q |
- |
- |
- |
- |
| American Brivision (holding) Corp |
4 Q |
- |
- |
- |
- |
| American Brivision (holding) Corp |
1 Q |
99.29 % |
- |
- |
- |
| Acadia Pharmaceuticals Inc |
1 Q |
97.95 % |
- |
- |
- |
| Acer Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Achillion Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Acelrx Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Acura Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Adial Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Adamis Pharmaceuticals Corp |
4 Q |
20.91 % |
- |
- |
- |
| Adamas Pharmaceuticals Inc |
1 Q |
98.01 % |
- |
- |
- |
| Advaxis Inc |
4 Q |
- |
- |
- |
- |
| Aegerion Pharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Aeterna Zentaris Inc |
4 Q |
22.93 % |
- |
- |
- |
| Affimed N v |
4 Q |
- |
- |
- |
- |
| Agex Therapeutics Inc |
1 Q |
94.64 % |
- |
- |
- |
| Agios Pharmaceuticals Inc |
1 Q |
- |
- |
- |
169.98 % |
| Aeglea Biotherapeutics Inc |
1 Q |
- |
- |
- |
- |
| Agile Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Aimmune Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Achaogen, Inc. |
4 Q |
- |
- |
- |
- |
| Akebia Therapeutics Inc |
1 Q |
33.84 % |
- |
45.26 % |
- |
| Akcea Therapeutics Inc |
2 Q |
93.66 % |
- |
- |
- |
| Akero Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Akorn Inc |
2 Q |
25.81 % |
- |
9.11 % |
- |
| Akari Therapeutics Plc |
4 Q |
- |
- |
- |
- |
| Akouos Inc |
1 Q |
- |
- |
- |
- |
| Albireo Pharma inc |
1 Q |
- |
- |
- |
- |
| Aldeyra Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Alimera Sciences Inc |
1 Q |
86.07 % |
- |
- |
- |
| Alkermes Plc |
1 Q |
83.69 % |
- |
- |
- |
| Allakos Inc |
1 Q |
- |
- |
- |
- |
| Allogene Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Alnylam Pharmaceuticals Inc |
1 Q |
87.03 % |
- |
- |
- |
| Alpine Immune Sciences Inc |
1 Q |
- |
- |
- |
- |
| Alexza Pharmaceuticals Inc. |
0 Q |
- |
- |
- |
- |
| Alexion Pharmaceuticals Inc |
1 Q |
92.34 % |
29.89 % |
28.84 % |
4.69 % |
| Alx Oncology Holdings Inc |
1 Q |
- |
- |
- |
- |
| Amag Pharmaceuticals inc |
3 Q |
85.67 % |
20.78 % |
- |
- |
| Amylin Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Ampio Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
| Amphastar Pharmaceuticals Inc |
1 Q |
43.63 % |
3.84 % |
7.11 % |
0.34 % |
| Amarin Corp Plcuk |
1 Q |
80.08 % |
- |
73.17 % |
0.15 % |
| Amneal Pharmaceuticals Inc |
1 Q |
38.85 % |
2.95 % |
22.04 % |
24.19 % |
| Applied Molecular Transport Inc |
1 Q |
- |
- |
- |
- |
| Anaptysbio inc |
1 Q |
- |
- |
- |
- |
| Anacor Pharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Chemomab Therapeutics Ltd |
1 Q |
- |
- |
- |
93.28 % |
| Ani Pharmaceuticals inc |
1 Q |
63.34 % |
0.16 % |
31.56 % |
- |
| Annexon Inc |
1 Q |
- |
- |
- |
- |
| Anthera Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Annovis Bio Inc |
1 Q |
- |
- |
- |
- |
| Apellis Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
| Applied Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Aptinyx Inc |
1 Q |
- |
- |
- |
- |
| Aravive Inc |
1 Q |
- |
- |
- |
- |
| Arcturus Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
- |
| Aridis Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Ardelyx inc |
1 Q |
84.81 % |
- |
- |
- |
| Argos Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Aralez Pharmaceuticals Inc. |
1 Q |
69.71 % |
- |
39.86 % |
- |
| Arena Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Arqule Inc |
3 Q |
- |
- |
- |
- |
| Arcutis Biotherapeutics Inc |
1 Q |
- |
- |
- |
- |
| Array Technologies Inc |
1 Q |
17.83 % |
1.17 % |
- |
55.56 % |
| Arvinas Inc |
1 Q |
- |
- |
- |
- |
| Ascendis Pharma A |
4 Q |
- |
- |
- |
- |
| Assertio Holdings inc |
1 Q |
85.22 % |
16.93 % |
- |
- |
| Athersys Inc |
1 Q |
- |
- |
- |
- |
| Actinium Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Athenex Inc |
1 Q |
60.01 % |
- |
- |
- |
| Avenue Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Aurinia Pharmaceuticals Inc |
1 Q |
94.75 % |
- |
- |
- |
| Avadel Pharmaceuticals Plc |
1 Q |
- |
- |
- |
- |
| Avedro Inc |
3 Q |
78.24 % |
- |
- |
- |
| Aveo Pharmaceuticals Inc |
1 Q |
92.81 % |
- |
- |
- |
| Atea Pharmaceuticals Inc |
1 Q |
- |
46.55 % |
- |
- |
| Aoxing Pharmaceutical Company, Inc. |
4 Q |
41.63 % |
- |
70.68 % |
- |
| Axsome Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Astrazeneca Plc |
4 Q |
80.09 % |
11.81 % |
29.42 % |
20.1 % |
| Bridgebio Pharma Inc |
1 Q |
- |
- |
- |
- |
| Atreca Inc |
1 Q |
- |
- |
- |
- |
| Bicycle Therapeutics Plc |
1 Q |
- |
- |
- |
- |
| Biodelivery Sciences International Inc |
1 Q |
85.81 % |
12.77 % |
11.83 % |
26.13 % |
| Beigene Ltd |
1 Q |
94.61 % |
10.98 % |
85.89 % |
- |
| Bausch Health Companies Inc |
1 Q |
72.18 % |
- |
6.46 % |
- |
| Biohaven Pharmaceutical Holding Company Ltd |
1 Q |
70.65 % |
- |
- |
- |
| Dnib Unwind, Inc. |
0 Q |
- |
- |
- |
- |
| Biovie Inc |
1 Q |
- |
- |
- |
- |
| Bellicum Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Bellerophon Therapeutics inc |
1 Q |
- |
- |
- |
- |
| Biolinerx Ltd |
4 Q |
- |
- |
- |
- |
| Biomarin Pharmaceutical Inc |
1 Q |
75.28 % |
3.57 % |
3.74 % |
20.44 % |
| Bristol Myers Squibb Co |
1 Q |
74.34 % |
18.32 % |
- |
- |
| Fitlife Brands, Inc. |
0 Q |
- |
- |
- |
- |
| Benitec Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Blueprint Medicines Corporation |
1 Q |
- |
- |
60.19 % |
27.26 % |
| Biostar Pharmaceuticals, Inc. |
3 Q |
- |
- |
- |
2.58 % |
| Biospecifics Technologies Corp |
3 Q |
- |
47.86 % |
- |
13.39 % |
| Bioxcel Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Baxalta Inc |
0 Q |
- |
- |
- |
- |
| Beyondspring Inc |
4 Q |
- |
- |
- |
- |
| Calithera Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Can fite Biopharma Ltd |
4 Q |
- |
- |
- |
- |
| Catabasis Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Cymabay Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Cambrex Corp |
2 Q |
35.53 % |
8.83 % |
- |
8.15 % |
| Columbia Laboratories Inc |
0 Q |
- |
- |
- |
- |
| Chemocentryx Inc |
1 Q |
- |
- |
- |
- |
| Celgene Corp |
3 Q |
96.31 % |
37.41 % |
52.88 % |
20.12 % |
| Chembio Diagnostics Inc |
1 Q |
59.33 % |
- |
- |
- |
| Melinta Therapeutics, Inc. |
3 Q |
48.25 % |
- |
- |
- |
| Ceres Ventures, Inc. |
0 Q |
- |
- |
- |
- |
| Contrafect Corp |
1 Q |
- |
- |
- |
- |
| Chiasma Inc |
1 Q |
96.52 % |
- |
- |
- |
| China Pharma Holdings, Inc. |
0 Q |
- |
- |
- |
- |
| Checkpoint Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| Colucid Pharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Cellectar Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Clearside Biomedical Inc |
1 Q |
- |
- |
- |
- |
| Celsion Corp |
1 Q |
- |
- |
- |
- |
| Clovis Oncology inc |
1 Q |
78.27 % |
- |
- |
- |
| Chimerix inc |
1 Q |
- |
- |
- |
- |
| Concert Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Coronado Biosciences Inc |
0 Q |
- |
- |
- |
- |
| Constellation Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Global Green Inc. |
0 Q |
- |
- |
- |
- |
| Cogent Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Collegium Pharmaceutical inc |
1 Q |
46.39 % |
13.07 % |
7.24 % |
28.35 % |
| Corium International, Inc. |
1 Q |
27.35 % |
- |
- |
- |
| Corcept Therapeutics Inc |
1 Q |
98.4 % |
29.54 % |
- |
20.11 % |
| Correvio Pharma Corp |
4 Q |
69.89 % |
- |
- |
- |
| China Pharma Holdings Inc |
1 Q |
11.56 % |
- |
- |
- |
| Cumberland Pharmaceuticals Inc |
1 Q |
77.06 % |
1.37 % |
1.61 % |
- |
| Catalyst Pharmaceuticals Inc |
1 Q |
84.5 % |
25.37 % |
- |
46.89 % |
| Corbus Pharmaceuticals Holdings Inc |
1 Q |
- |
- |
- |
- |
| Cormedix Inc |
1 Q |
30.5 % |
- |
- |
- |
| Crinetics Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Crispr Therapeutics Ag |
0 Q |
- |
- |
- |
- |
| Corvus Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Cti Biopharma Corp |
1 Q |
- |
- |
- |
- |
| Innovation Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Catalent Inc |
1 Q |
34.71 % |
22.01 % |
14.72 % |
15.5 % |
| Celyad Oncology Sa |
4 Q |
- |
- |
- |
- |
| Cyclacel Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Cyclerion Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| China Yct International Group, Inc. |
2 Q |
42.72 % |
22.15 % |
12.01 % |
12.09 % |
| Cymabay Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Cytokinetics Incorporated |
1 Q |
- |
- |
- |
- |
| Dara Biosciences, Inc. |
4 Q |
62.37 % |
- |
- |
- |
| Dar Bioscience Inc |
1 Q |
- |
- |
- |
- |
| Dermira, Inc. |
3 Q |
83.25 % |
- |
- |
- |
| Diamedica Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Dicerna Pharmaceuticals Inc |
1 Q |
- |
- |
67.95 % |
- |
| Durect Corp |
1 Q |
84.09 % |
- |
- |
- |
| Dynavax Technologies Corp |
1 Q |
70.45 % |
1.07 % |
56.36 % |
- |
| Auris Medical Holding Ltd. |
2 Q |
- |
- |
- |
- |
| Endocyte Inc |
1 Q |
- |
- |
- |
- |
| Zyla Life Sciences |
1 Q |
81.66 % |
- |
- |
- |
| Eagle Pharmaceuticals inc |
1 Q |
79.53 % |
- |
5.03 % |
7.87 % |
| Elanco Animal Health Inc |
1 Q |
54.19 % |
- |
0.72 % |
- |
| Eledon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Elite Pharmaceuticals Inc |
4 Q |
56.29 % |
33.28 % |
17.32 % |
48.48 % |
| Emerald Health Therapeutics Inc |
4 Q |
- |
- |
- |
14616.17 % |
| Emisphere Technologies Inc |
1 Q |
78.83 % |
- |
- |
- |
| Endo International Plc |
1 Q |
57.48 % |
5.78 % |
25.05 % |
- |
| Enlivex Therapeutics Ltd |
4 Q |
- |
- |
- |
- |
| Enanta Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Evolus Inc |
1 Q |
59.91 % |
52.29 % |
- |
- |
| Essa Pharma inc |
4 Q |
- |
- |
- |
- |
| Epirus Biopharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Epizyme Inc |
1 Q |
62.61 % |
- |
- |
- |
| Esperion Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Eton Pharmaceuticals Inc |
1 Q |
86.64 % |
43 % |
32.09 % |
- |
| Entasis Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
- |
| Evofem Biosciences Inc |
1 Q |
54.21 % |
- |
- |
- |
| Evoke Pharma Inc |
1 Q |
- |
- |
- |
- |
| Eyegate Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Fortress Biotech Inc |
1 Q |
66.27 % |
- |
- |
- |
| Forte Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Fibrocell Science, Inc. |
3 Q |
- |
- |
- |
- |
| Fibrogen Inc |
1 Q |
- |
- |
- |
- |
| Foghorn Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Flexion Therapeutics Inc |
1 Q |
75.25 % |
- |
- |
- |
| Fresenius Medical Care Ag and Co Kgaa |
4 Q |
31.01 % |
8.04 % |
- |
11.64 % |
| Antriabio, Inc. |
0 Q |
- |
- |
- |
- |
| Amicus Therapeutics inc |
1 Q |
90.15 % |
- |
32.96 % |
- |
| Five Prime Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| F star Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Fitlife Brands Inc |
1 Q |
49.97 % |
27.35 % |
4.69 % |
63.33 % |
| Forty Seven Inc |
4 Q |
- |
- |
- |
- |
| Fulcrum Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Futureworld Corp. |
0 Q |
- |
- |
- |
- |
| Galectin Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Globeimmune Inc |
0 Q |
- |
- |
- |
- |
| Generation Bio Co |
1 Q |
- |
- |
- |
- |
| Gb Sciences Inc |
4 Q |
- |
- |
- |
- |
| Global Blood Therapeutics Inc |
1 Q |
98.5 % |
- |
- |
- |
| Geron Corp |
1 Q |
- |
- |
- |
- |
| Guardion Health Sciences Inc |
1 Q |
42.98 % |
- |
- |
- |
| Galmed Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
65.16 % |
| Galapagos Nv |
4 Q |
- |
- |
- |
- |
| Galecto Inc |
1 Q |
- |
- |
- |
- |
| Glycomimetics Inc |
1 Q |
- |
- |
- |
- |
| Generex Biotechnology Corp |
4 Q |
- |
- |
- |
- |
| Genprex Inc |
1 Q |
- |
- |
- |
- |
| Genspera Inc |
0 Q |
- |
- |
- |
- |
| Genvec Inc |
1 Q |
- |
- |
- |
- |
| Global Green Inc. |
0 Q |
- |
- |
- |
- |
| Graybug Vision Inc |
1 Q |
- |
- |
- |
- |
| Grifols Sa |
4 Q |
- |
- |
- |
10.55 % |
| Glaxosmithkline Plc |
4 Q |
65.68 % |
18.73 % |
18.45 % |
30.7 % |
| Gw Pharmaceuticals Plc |
1 Q |
92.26 % |
- |
- |
- |
| Hutchison China Meditech Limited |
4 Q |
21.56 % |
- |
97.99 % |
- |
| Hepion Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
| Hookipa Pharma Inc |
1 Q |
- |
- |
- |
- |
| Hoth Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Health right Discoveries Inc |
3 Q |
81.21 % |
- |
- |
- |
| Harmony Biosciences Holdings Inc |
1 Q |
82.56 % |
12.38 % |
- |
- |
| Harrow Health Inc |
1 Q |
75.59 % |
1.41 % |
14.27 % |
40.92 % |
| Heron Therapeutics Inc |
1 Q |
54.01 % |
- |
- |
- |
| Hospira Inc |
4 Q |
8.03 % |
0.84 % |
4.15 % |
- |
| Histogen Inc |
1 Q |
- |
- |
- |
- |
| Heat Biologics Inc |
1 Q |
- |
- |
- |
- |
| Processa Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Horizon Therapeutics Public Limited Company |
1 Q |
70.69 % |
- |
- |
7.98 % |
| Imagenetix Inc |
0 Q |
- |
- |
- |
- |
| Iaso Biomed, Inc. |
3 Q |
- |
- |
- |
- |
| Ibio Inc |
1 Q |
35.56 % |
- |
- |
- |
| Intercept Pharmaceuticals inc |
1 Q |
99.01 % |
- |
42.52 % |
- |
| Ideaya Biosciences Inc |
1 Q |
- |
- |
- |
- |
| I mab |
4 Q |
- |
30.53 % |
- |
8.37 % |
| Immune Design Corp. |
1 Q |
98.61 % |
- |
- |
- |
| Immunogen inc |
1 Q |
- |
- |
- |
- |
| Immutep Ltd |
2 Q |
- |
- |
- |
- |
| Immunome inc |
1 Q |
- |
- |
- |
- |
| Immune Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Imara Inc |
1 Q |
- |
- |
- |
- |
| Immunocellular Therapeutics, Ltd. |
1 Q |
- |
- |
- |
- |
| Immunic Inc |
1 Q |
- |
- |
- |
- |
| Innocoll Holdings Plc |
1 Q |
- |
- |
- |
- |
| Insmed Inc |
1 Q |
75.52 % |
- |
- |
- |
| Inspire Medical Systems inc |
1 Q |
85.18 % |
- |
- |
- |
| Insite Vision Inc |
0 Q |
- |
- |
- |
- |
| Insys Therapeutics, Inc. |
1 Q |
40.04 % |
- |
- |
- |
| Innoviva inc |
1 Q |
- |
- |
42.57 % |
55.67 % |
| Inozyme Pharma Inc |
1 Q |
- |
- |
- |
- |
| Ionis Pharmaceuticals Inc |
1 Q |
97.69 % |
- |
14.78 % |
- |
| Intellipharmaceutics International Inc |
4 Q |
- |
- |
9.81 % |
- |
| Impax Laboratories, Llc |
1 Q |
21.27 % |
- |
- |
- |
| Ironwood Pharmaceuticals inc |
1 Q |
- |
44.94 % |
85.44 % |
402.46 % |
| Iveric Bio Inc |
1 Q |
- |
- |
- |
- |
| Intra cellular Therapies Inc |
1 Q |
- |
- |
- |
- |
| Jaguar Health Inc |
1 Q |
53.02 % |
- |
- |
- |
| Jazz Pharmaceuticals Plc |
4 Q |
- |
- |
11.83 % |
7.1 % |
| Johnson and Johnson |
1 Q |
68.36 % |
27.76 % |
- |
23.57 % |
| Juniper Pharmaceuticals Inc |
1 Q |
41.86 % |
4.97 % |
- |
2.42 % |
| Kala Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
| Kalobios Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Kalvista Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Humanigen Inc |
1 Q |
- |
- |
- |
- |
| Kyto Technology and Life Science Inc |
3 Q |
- |
- |
- |
- |
| Kadmon holdings inc |
1 Q |
82.95 % |
- |
- |
- |
| Chinook Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Keryx Biopharmaceuticals Inc |
1 Q |
52.64 % |
- |
- |
- |
| Keyuan Petrochemicals, Inc. |
0 Q |
- |
- |
- |
- |
| Kindred Biosciences Inc |
1 Q |
75.37 % |
- |
53.9 % |
- |
| Kamada Ltd |
4 Q |
35.69 % |
12.86 % |
- |
9.59 % |
| Kempharm Inc |
1 Q |
- |
- |
- |
- |
| Kiniksa Pharmaceuticals Ltd |
1 Q |
- |
- |
- |
- |
| Karyopharm Therapeutics Inc |
1 Q |
- |
- |
3.8 % |
- |
| Kronos Bio Inc |
1 Q |
- |
- |
- |
- |
| Keros Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Karuna Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Kintara Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| China Shenghuo Pharmaceutical Holdings Inc |
0 Q |
- |
- |
- |
- |
| Kura Oncology Inc |
1 Q |
- |
- |
- |
- |
| Kythera Biopharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Lannett Co Inc |
1 Q |
23.54 % |
- |
41.88 % |
- |
| Lifevantage Corp |
1 Q |
82.9 % |
3.34 % |
- |
34.1 % |
| Ligand Pharmaceuticals Incorporated |
1 Q |
78.63 % |
32.83 % |
- |
5.51 % |
| Eli Lilly And Company |
1 Q |
72.4 % |
19.91 % |
- |
109.81 % |
| Liminal Biosciences Inc |
4 Q |
- |
- |
- |
- |
| Loxo Oncology, Inc. |
1 Q |
- |
- |
- |
- |
| Lipocine Inc |
1 Q |
- |
- |
- |
- |
| Leap Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Larimar Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Lumos Pharma Inc |
1 Q |
- |
- |
- |
- |
| Lexicon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Merrimack Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Marizyme Inc |
1 Q |
- |
- |
- |
- |
| Mabcure Inc. |
0 Q |
- |
- |
- |
- |
| Mustang Bio inc |
4 Q |
- |
- |
- |
- |
| Moleculin Biotech Inc |
1 Q |
- |
- |
- |
- |
| Seres Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Medicines Co |
3 Q |
- |
- |
- |
- |
| Medavail Holdings Inc |
1 Q |
7.95 % |
- |
- |
- |
| Medivation, Inc. |
4 Q |
- |
2.87 % |
- |
- |
| Mei Pharma Inc |
1 Q |
83.25 % |
- |
- |
- |
| Macrogenics Inc |
1 Q |
99.9 % |
- |
- |
- |
| Magenta Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Mirum Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Milestone Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Stealth Biotherapeutics Corp |
4 Q |
- |
- |
- |
- |
| Millendo Therapeutics inc |
1 Q |
- |
- |
- |
- |
| Mmrglobal, Inc. |
0 Q |
- |
- |
- |
- |
| Mannkind Corporation |
1 Q |
81.1 % |
- |
- |
- |
| Mallinckrodt Plc |
1 Q |
44.87 % |
- |
1.88 % |
- |
| Medicinova Inc |
1 Q |
- |
- |
- |
- |
| Morphosys Ag |
4 Q |
97.2 % |
29.87 % |
13.52 % |
15.76 % |
| Mereo Biopharma Group Plc |
4 Q |
- |
- |
- |
- |
| Merck and Co Inc |
1 Q |
69.62 % |
26.37 % |
- |
25.76 % |
| Marker Therapeutics inc |
1 Q |
- |
- |
- |
- |
| Moderna Inc |
1 Q |
90.04 % |
63.04 % |
- |
37.55 % |
| Marinus Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Mersana Therapeutics inc |
1 Q |
- |
- |
- |
- |
| Mirati Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Metacrine Inc |
1 Q |
- |
- |
- |
- |
| Molecular Templates Inc |
1 Q |
- |
- |
- |
142.44 % |
| Abvc Biopharma Inc |
1 Q |
99.53 % |
- |
- |
- |
| Midatech Pharma Plc |
4 Q |
- |
- |
- |
- |
| Mylan N v |
3 Q |
38.98 % |
6.25 % |
11.52 % |
2.25 % |
| Myovant Sciences Ltd |
1 Q |
98.78 % |
- |
- |
- |
| Nature s Sunshine Products inc |
1 Q |
73.66 % |
4.05 % |
- |
16.45 % |
| Nabriva Therapeutics Plc |
1 Q |
97.55 % |
- |
- |
- |
| Neubase Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Novabay Pharmaceuticals Inc |
1 Q |
74.82 % |
- |
- |
- |
| Nucana Plc |
4 Q |
- |
- |
- |
- |
| Neos Therapeutics Inc |
3 Q |
59.15 % |
- |
0.52 % |
- |
| Neptune Wellness Solutions Inc |
1 Q |
- |
- |
33.2 % |
- |
| Minerva Neurosciences inc |
1 Q |
- |
- |
- |
9.93 % |
| Ngm Biopharmaceuticals Inc |
1 Q |
- |
- |
5.08 % |
- |
| China Nuokang Bio-pharmaceutical Inc. |
0 Q |
- |
- |
- |
- |
| Nektar Therapeutics |
1 Q |
75.66 % |
- |
- |
- |
| Nkarta Inc |
1 Q |
- |
- |
- |
- |
| 9 Meters Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Novan Inc |
1 Q |
- |
- |
- |
- |
| Neurobo Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Nurix Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Inergetics Inc |
0 Q |
- |
- |
- |
- |
| Nephrogenex, Inc. |
0 Q |
- |
- |
- |
- |
| Inspyr Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Intec Pharma Ltd |
1 Q |
- |
- |
- |
- |
| Neurotrope inc |
3 Q |
- |
- |
- |
46.07 % |
| Nexvet Biopharma Plc |
1 Q |
- |
- |
- |
- |
| Novelion Therapeutics Inc |
1 Q |
52.74 % |
- |
21.01 % |
- |
| Novelos Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Novartis Ag |
4 Q |
69.7 % |
16.17 % |
22.27 % |
14.24 % |
| Northwest Biotherapeutics Inc |
1 Q |
- |
- |
- |
- |
| Northwest Biotherapeutics Inc |
0 Q |
- |
- |
- |
- |
| Nextcure Inc |
1 Q |
- |
- |
- |
- |
| Obseva Sa |
4 Q |
- |
- |
- |
- |
| Ocera Therapeutics, Inc. |
3 Q |
- |
- |
- |
- |
| Ocular Therapeutix Inc |
1 Q |
87.85 % |
42.51 % |
- |
- |
| Oragenics Inc |
1 Q |
- |
- |
- |
- |
| Oncomed Pharmaceuticals Inc |
1 Q |
- |
- |
10.8 % |
- |
| Omeros Corporation |
1 Q |
98.75 % |
- |
- |
- |
| Oncorus Inc |
1 Q |
- |
- |
- |
- |
| Oncosec Medical Inc |
4 Q |
- |
- |
- |
- |
| Oncolix, Inc. |
1 Q |
- |
- |
- |
- |
| Oncolytics Biotech Inc |
4 Q |
- |
- |
- |
- |
| Onconova Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Opko Health Inc |
1 Q |
37.74 % |
5.7 % |
3.17 % |
7.34 % |
| Wize Pharma Inc |
3 Q |
- |
- |
- |
- |
| Optinose Inc |
1 Q |
- |
- |
- |
- |
| Orexigen Therapeutics, Inc. |
3 Q |
78.64 % |
- |
47.15 % |
- |
| Organogenesis Holdings Inc |
1 Q |
75.14 % |
9.7 % |
- |
43.7 % |
| Oric Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Oramed Pharmaceuticals Inc |
1 Q |
- |
- |
- |
42.75 % |
| Oragenics Inc |
0 Q |
- |
- |
- |
- |
| Otonomy Inc |
1 Q |
- |
- |
- |
- |
| Ovid Therapeutics Inc |
1 Q |
- |
84.46 % |
77.27 % |
128.18 % |
| One World Pharma, Inc. |
1 Q |
- |
- |
- |
- |
| Phibro Animal Health Corp |
1 Q |
32.67 % |
5.74 % |
6.88 % |
21.19 % |
| Pandion Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| Prestige Consumer Healthcare Inc |
1 Q |
57.64 % |
- |
- |
12.7 % |
| Panbela Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Puma Biotechnology Inc |
1 Q |
69.89 % |
16.84 % |
10.55 % |
- |
| Pacira Biosciences inc |
1 Q |
73.66 % |
8.71 % |
- |
28.31 % |
| Aratana Therapeutics, Inc. |
1 Q |
79.36 % |
- |
- |
- |
| Pfizer Inc |
1 Q |
71.12 % |
33.51 % |
- |
16.96 % |
| Pfenex Inc |
2 Q |
12.93 % |
- |
- |
- |
| Progenics Pharmaceuticals Inc |
1 Q |
75.06 % |
- |
- |
- |
| Phasebio Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Phio Pharmaceuticals Corp |
1 Q |
- |
- |
- |
- |
| Peak Pharmaceuticals, Inc. |
1 Q |
- |
- |
- |
- |
| Pliant Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Plx Pharma Inc |
1 Q |
- |
- |
- |
- |
| Pmv Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| One World Pharma Inc |
1 Q |
67.45 % |
- |
- |
- |
| Pozen Inc |
0 Q |
- |
- |
- |
- |
| Propanc Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Avid Bioservices Inc |
4 Q |
28.44 % |
10.12 % |
- |
7.98 % |
| Praxis Precision Medicines Inc |
1 Q |
- |
- |
- |
- |
| Perrigo Company Plc |
1 Q |
36.48 % |
3.77 % |
- |
0.88 % |
| Principia Biopharma Inc |
2 Q |
- |
21.62 % |
- |
- |
| Prophase Labs Inc |
1 Q |
58.46 % |
6.92 % |
- |
- |
| Proqr Therapeutics N v |
4 Q |
- |
- |
- |
- |
| Prothena Corporation Public Limited Company |
1 Q |
- |
- |
- |
- |
| Paratek Pharmaceuticals Inc |
1 Q |
83.25 % |
- |
- |
- |
| Protect Pharmaceutical Corp |
2 Q |
- |
- |
- |
- |
| Protalex Inc |
3 Q |
- |
- |
- |
- |
| Provention Bio Inc |
1 Q |
- |
- |
- |
- |
| Proto Script Pharmaceutical Corp |
3 Q |
84.84 % |
- |
- |
- |
| Ptc Therapeutics inc |
1 Q |
- |
- |
- |
- |
| Patheon N.v. |
1 Q |
29.11 % |
5.71 % |
- |
- |
| Portola Pharmaceuticals inc |
1 Q |
83.63 % |
- |
- |
- |
| Palatin Technologies Inc |
1 Q |
37.53 % |
- |
- |
- |
| Pernix Therapeutics Holdings, Inc. |
1 Q |
- |
- |
- |
- |
| Provectus Biopharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Phaserx, Inc. |
3 Q |
- |
- |
- |
95.89 % |
| Novelion Therapeutics Inc. |
1 Q |
50.86 % |
- |
- |
- |
| Uniqure N v |
1 Q |
- |
- |
- |
- |
| Ultragenyx Pharmaceutical Inc |
1 Q |
94.78 % |
- |
- |
- |
| Ra Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Rasna Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| Rocket Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Rock Creek Pharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Redhill Biopharma Ltd |
4 Q |
42.68 % |
- |
45.1 % |
549.43 % |
| Radius Health inc |
1 Q |
92.67 % |
- |
40.33 % |
- |
| Dr Reddys Laboratories Ltd |
1 Q |
53.84 % |
11.18 % |
- |
12.6 % |
| Regeneron Pharmaceuticals Inc |
1 Q |
92.76 % |
44.1 % |
- |
37.96 % |
| Reliv International Inc |
3 Q |
73.58 % |
- |
7.03 % |
- |
| Recro Pharma Inc |
1 Q |
14.68 % |
- |
- |
- |
| Reata Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Ocuphire Pharma Inc |
1 Q |
- |
- |
- |
- |
| Regulus Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Rigel Pharmaceuticals Inc |
1 Q |
99.61 % |
48.75 % |
- |
- |
| Relypsa Inc |
0 Q |
- |
- |
- |
- |
| Avidity Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Rosetta Genomics Ltd. |
4 Q |
24.42 % |
- |
- |
385.86 % |
| Raptor Pharmaceutical Corp |
0 Q |
- |
- |
- |
- |
| Repare Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Qualigen Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Revance Therapeutics Inc |
1 Q |
46.95 % |
- |
- |
- |
| Reviva Pharmaceuticals Holdings Inc |
1 Q |
- |
- |
- |
- |
| Prometheus Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Rhythm Pharmaceuticals inc |
1 Q |
88.57 % |
- |
- |
- |
| Rezolute Inc |
1 Q |
- |
- |
- |
- |
| Sage Therapeutics Inc |
1 Q |
88.19 % |
- |
- |
46.56 % |
| Cassava Sciences Inc |
1 Q |
- |
- |
- |
- |
| Sciclone Pharmaceuticals Inc |
2 Q |
- |
27.39 % |
35.9 % |
19.1 % |
| Sucampo Pharmaceuticals, Inc. |
3 Q |
71.54 % |
16.92 % |
- |
- |
| Scopus Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Scynexis inc |
1 Q |
- |
- |
- |
- |
| Seelos Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Sesen Bio Inc |
1 Q |
- |
- |
- |
2318.8 % |
| Sagent Pharmaceuticals, Inc. |
0 Q |
- |
- |
- |
- |
| Signpath Pharma, Inc. |
0 Q |
- |
- |
- |
- |
| Synergy Pharmaceuticals, Inc. |
2 Q |
68.3 % |
- |
- |
- |
| Shire Plc |
3 Q |
85.05 % |
6.94 % |
- |
13.03 % |
| Shire Plc |
4 Q |
69.52 % |
74.92 % |
6.35 % |
17.05 % |
| Shuttle Pharmaceuticals, Inc. |
3 Q |
- |
- |
- |
- |
| Siga Technologies Inc |
1 Q |
94.79 % |
- |
- |
56.08 % |
| Sunset Island Group |
2 Q |
- |
- |
- |
- |
| Sio Gene Therapies Inc |
4 Q |
- |
- |
- |
- |
| Skystar Bio-pharmaceutical Co |
0 Q |
- |
- |
- |
- |
| Skye Bioscience Inc |
1 Q |
- |
- |
- |
- |
| Sellas Life Sciences Group Inc |
1 Q |
98.19 % |
- |
- |
- |
| Summit Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Sibannac, Inc. |
3 Q |
- |
- |
- |
- |
| Sanofi |
4 Q |
67.47 % |
33.05 % |
25.23 % |
19.56 % |
| Sophiris Bio Inc. |
3 Q |
- |
- |
- |
- |
| Spectrum Pharmaceuticals Inc |
1 Q |
- |
- |
- |
11.04 % |
| Spruce Biosciences Inc |
1 Q |
- |
- |
- |
- |
| Sarepta Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Sierra Oncology Inc |
1 Q |
- |
- |
- |
- |
| Steadymed Ltd. |
1 Q |
- |
- |
- |
176.29 % |
| Stemline Therapeutics Inc |
1 Q |
92.78 % |
- |
- |
- |
| Stoke Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Supernus Pharmaceuticals inc |
1 Q |
88.58 % |
4.35 % |
- |
15.47 % |
| Sinovac Biotech Ltd |
4 Q |
86.84 % |
36.27 % |
- |
16.53 % |
| Savara Inc |
1 Q |
- |
- |
- |
- |
| Synlogic Inc |
1 Q |
- |
- |
- |
- |
| Synthetic Biologics Inc |
1 Q |
- |
- |
- |
- |
| Syros Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
| Taro Pharmaceutical Industries Ltd |
1 Q |
62 % |
37.93 % |
- |
11.59 % |
| Theravance Biopharma inc |
1 Q |
- |
- |
- |
- |
| Tricida Inc |
1 Q |
- |
- |
- |
- |
| Teva Pharmaceutical Industries Ltd |
1 Q |
47.16 % |
2.11 % |
- |
- |
| Taiwan Liposome Company Ltd |
4 Q |
- |
- |
- |
- |
| Teligent Inc |
4 Q |
- |
- |
- |
- |
| Tetralogic Pharmaceuticals Corp |
0 Q |
- |
- |
- |
- |
| Tiziana Life Sciences Plc |
4 Q |
- |
- |
- |
- |
| Timber Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Tonix Pharmaceuticals Holding Corp |
1 Q |
- |
- |
- |
- |
| Tianyin Pharmaceutical Co., Inc. |
4 Q |
44.65 % |
12.16 % |
91.97 % |
6.99 % |
| Turning Point Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Trillium Therapeutics Inc |
1 Q |
- |
- |
- |
30.19 % |
| Trevi Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Trevena inc |
1 Q |
22.01 % |
- |
- |
- |
| Transcept Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Tesaro, Inc. |
1 Q |
76.54 % |
- |
- |
- |
| Titan Pharmaceuticals Inc |
1 Q |
83.87 % |
- |
- |
- |
| Tetraphase Pharmaceuticals Inc |
1 Q |
22.51 % |
- |
- |
- |
| Travere Therapeutics Inc |
1 Q |
96.53 % |
- |
- |
- |
| Therapeuticsmd Inc |
1 Q |
76.41 % |
- |
- |
- |
| Shineco Inc |
1 Q |
- |
- |
74.83 % |
- |
| Tyme Technologies Inc |
4 Q |
- |
- |
- |
- |
| United Therapeutics Corporation |
1 Q |
93.93 % |
7.47 % |
24.69 % |
12.27 % |
| Vascular Biogenics Ltd |
4 Q |
57.27 % |
- |
- |
78.35 % |
| Vaccinex Inc |
1 Q |
- |
- |
- |
- |
| Vaccinogen Inc |
0 Q |
- |
- |
- |
- |
| Viela Bio Inc |
3 Q |
- |
- |
- |
- |
| Vincerx Pharma Inc |
1 Q |
- |
- |
- |
- |
| Viracta Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Viking Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Vanda Pharmaceuticals Inc |
1 Q |
90.38 % |
13.8 % |
17.71 % |
7.03 % |
| Verrica Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Verona Pharma Plc |
1 Q |
- |
- |
- |
- |
| Vertex Pharmaceuticals Inc |
1 Q |
88.85 % |
37.88 % |
18.79 % |
33.16 % |
| Verastem Inc |
1 Q |
- |
- |
- |
- |
| Vitae Pharmaceuticals, Inc |
0 Q |
- |
- |
- |
- |
| Viatris Inc |
1 Q |
25.45 % |
- |
- |
- |
| Vtv Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Vivus Inc |
4 Q |
76.99 % |
- |
- |
- |
| Vyne Therapeutics Inc |
1 Q |
85.41 % |
- |
- |
375.26 % |
| World Health Energy Holdings Inc |
1 Q |
- |
- |
- |
- |
| Wuxi Pharmatech (cayman) Inc. |
0 Q |
- |
- |
- |
- |
| Xbiotech Inc |
1 Q |
52.49 % |
- |
51.81 % |
- |
| Exicure Inc |
1 Q |
- |
- |
- |
- |
| Xenon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Xeris Pharmaceuticals Inc |
1 Q |
77.72 % |
- |
- |
74.12 % |
| Xencor Inc |
1 Q |
- |
- |
39.51 % |
- |
| Xenoport Inc |
4 Q |
78.6 % |
- |
- |
- |
| Xoma Corporation |
4 Q |
- |
64.81 % |
- |
17.24 % |
| Xtl Biopharmaceuticals Ltd |
4 Q |
- |
- |
- |
- |
| Y mabs Therapeutics inc |
1 Q |
98.27 % |
- |
- |
- |
| Yumanity Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Zogenix Inc |
1 Q |
95.06 % |
- |
- |
- |
| Zentalis Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Zosano Pharma Corporation |
1 Q |
37.21 % |
- |
- |
- |
| Zs Pharma, Inc. |
0 Q |
- |
- |
- |
- |
| Zoetis Inc |
1 Q |
70.66 % |
29.82 % |
- |
48.99 % |
| Zynerba Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
